Kirkland & Ellis advised EDDA Healthcare and Technology Holding Limited on the deal.
EDDA Healthcare and Technology Holding Limited, a pioneer in the field of intelligent robotic solutions for precision surgery, completed a $150 million financing round. Softbank Vision Fund 2 led this investment round with participation from OrbiMed and 3W Fund.
EDDA Technology brings innovative precision 3D medical imaging solutions to support physicians and enable improved workflow and patient care in robotic surgery. The company’s end-to-end enabling IQQA® platform supports pre-surgical planning and simulation, intra-operative navigation, and post-operative evaluation. The IQQA® products and services have been commercially adopted in hundreds of hospital departments, including Mayo Clinic in the US, and Peking Union Medical College Hospital, West China Hospital, and Shanghai Ruijin Hospital in China.
The Kirkland team advising EDDA was led by capital markets partner Mengyu Lu (Picture).
Involved fees earner: Mengyu Lu – Kirkland & Ellis;
Law Firms: Kirkland & Ellis;
Clients: SoftBank Vision Fund II;